The Federal Trade Commission has opened an antitrust investigation into Epic Systems, the dominant electronic health record (EHR) vendor, focusing on how the company grants or withholds access to patient data and whether employment agreements restrict workers from joining competitors. The probe comes as Epic unveiled a suite of new artificial intelligence tools at its annual conference, intensifying concerns among smaller health tech companies about their ability to compete in an AI-driven healthcare market.

What Is the FTC Investigating About Epic?

According to reports, the FTC has contacted several people who work in or advise healthcare businesses as part of the investigation into Epic. The agency is examining two primary areas: how Epic controls access to patient data through its platform, and whether the company's employment agreements prevent its workers from moving to competing healthcare technology firms.

Epic has denied engaging in anticompetitive behavior. In a statement to MedCity News, the company emphasized its commitment to data sharing standards. "Epic does more to support standards-based data-sharing than any other EHR vendor. We were the first EHR to connect to TEFCA, the federally sponsored interoperability network, and the first to do standards-based diagnostic image exchange. We publish more than 1,000 APIs and interfaces on open.epic for developers to exchange data with Epic. Nearly 3,000 apps use open.epic resources today," an Epic spokesperson said.

How Is Epic Expanding Its AI Capabilities Despite Regulatory Scrutiny?

Despite the regulatory pressure, Epic is moving forward aggressively with artificial intelligence expansion. CEO Judy Faulkner unveiled several new AI tools and platforms designed to deepen the company's integration into hospital workflows.

• Agent Factory: A new platform that allows hospitals to build and monitor their own AI agents tailored to their specific needs and workflows.
• Cosmos Curiosity: A predictive tool that draws on Epic's massive database of de-identified patient information to flag risks like hospital readmission and help clinicians answer population-level health questions.
• Appointment Preparation Tool: A new AI tool that pulls together patient data to help clinicians prepare for appointments more efficiently.
• Enhanced AI Assistants: Expanded capabilities for Art, Emmie, and Penny, Epic's existing AI assistants designed for clinicians, patients, and revenue cycle staff respectively.

These announcements signal that Epic intends to absorb capabilities that were previously handled by standalone health tech vendors, effectively expanding its footprint across the entire hospital technology ecosystem.

Why Are Smaller Health Tech Companies Still Confident They Can Compete?

Despite Epic's aggressive expansion, some health tech executives argue that differentiation will not come from feature announcements alone. Vikram Khanna, chief revenue officer at healthcare AI startup Suki, explained that the real competitive advantage lies elsewhere. "Everyone can announce the same roadmap, and increasingly they are. The real differentiation will come down to three things: execution, outcomes and architecture. Did you actually build it well? Can you prove it delivers value? And can it work across the entire health system, not just within one technology stack? Features will converge. Execution and outcomes are much harder to copy," Khanna stated.

"Everyone can announce the same roadmap, and increasingly they are. The real differentiation will come down to three things: execution, outcomes and architecture. Did you actually build it well? Can you prove it delivers value? And can it work across the entire health system, not just within one technology stack? Features will converge. Execution and outcomes are much harder to copy," said Vikram Khanna.

Vikram Khanna, Chief Revenue Officer at Suki

Tim Showalter, chief medical officer at healthcare AI platform Viz.Ai, offered a different perspective on how smaller companies can carve out space in the market. He argued that clinical AI agents require a level of rigor and architectural sophistication that EHR platforms may not be designed to deliver. "The best health tech companies don't compete with the EHR, they do what the EHR can't," Showalter stated.

"The best health tech companies don't compete with the EHR, they do what the EHR can't," said Tim Showalter.

Tim Showalter, Chief Medical Officer at Viz.Ai

What Does This Mean for Healthcare AI Competition?

The FTC investigation into Epic arrives at a critical moment for healthcare technology. As EHR vendors increasingly integrate AI capabilities directly into their platforms, the question of whether smaller, specialized AI companies can survive becomes more urgent. The regulatory scrutiny suggests that policymakers are concerned about market concentration in healthcare technology, particularly around data access and employment practices that could limit competition.

Epic's dominance in the EHR market, combined with its aggressive AI expansion, creates a scenario where the company controls both the infrastructure that hospitals rely on and the advanced tools that clinicians use daily. For competitors, the path forward appears to depend less on matching Epic's feature announcements and more on proving superior execution, demonstrable clinical outcomes, and the ability to work seamlessly across different hospital systems and technology stacks.

The outcome of the FTC investigation could reshape how Epic and other large healthcare technology vendors operate, potentially opening space for smaller competitors or reinforcing the company's market position depending on what regulators find.